Vertex Pharmaceuticals
VRTX
VRTX
1,101 hedge funds and large institutions have $65.6B invested in Vertex Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 132 funds opening new positions, 358 increasing their positions, 437 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,101
Holders Change
+35
Holders Change %
+3.28%
% of All Funds
18.62%
Holding in Top 10
32
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+33.33%
% of All Funds
0.54%
New
132
Increased
358
Reduced
437
Closed
78
Calls
$467M
Puts
$480M
Net Calls
-$12.8M
Net Calls Change
+$263M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$4.72B |
| 2 |
Jennison Associates
New York
|
$499M |
| 3 |
BlackRock
New York
|
$7.08B |
| 4 |
Morgan Stanley
New York
|
$515M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
$1.22B |
Top Sellers
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
$1.26B |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
$2.62B |
| 3 |
ClearBridge Investments
New York
|
$1.2B |
| 4 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
$657K |
| 5 |
D.E. Shaw & Co
New York
|
$78.5M |
